(A) | |||
---|---|---|---|
MTC | Studies (n) | FE: effect size [95% CrI] | RE: effect size [95% CrI] |
BCVA mean change from baseline | 10 studies (n = 3060)* | MD = 4.67 [2.45–6.87] | MD = 4.67 [1.85–7.52] |
Gain ≥ 10 ETDRS letters | 6 studies (n = 2810)** | RR = 1.32 [0.98–1.78] | RR = 1.19 [0.90–1.57] |
OR = 1.64 [0.97–2.78] | OR = 1.59 [0.75–3.35] | ||
Loss ≥ 10 ETDRS letters | 6 studies (n = 2810)** | RR = 0.27 [0.07–0.90] | RR = 0.28 [0.06–1.29] |
OR = 0.27 [0.07–0.90] | OR = 0.26 [0.05–1.31] | ||
Gain ≥ 15 ETDRS letters | 6 studies (n = 2810)** | RR = 1.78 [0.96–3.29] | RR = 1.42 [0.93–2.24] |
OR = 1.90 [0.95–3.75] | OR = 1.87 [0.87–4.16] | ||
Loss ≥ 15 ETDRS letters | 6 studies (n = 2810)** | RR = 0.13 [0.004–1.35] | RR = 0.14 [0.007–1.52] |
OR = 0.13 [0.004–1.35] | OR = 0.14 [0.006–1.53] | ||
(B) | |||
Bucher | Studies (n) | FE: effect size [95% CI] | RE: effect size [95% CI] |
BCVA mean change from baseline | 4 studies (n = 1611)*** | MD = 4.82 [2.52–7.11] | MD = 4.82 [2.52–7.11] |
Gain ≥ 10 ETDRS letters | 4 studies (n = 1611)*** | RR = 0.993 [0.65–1.52] | RR = 1.00 [0.60–1.66] |
OR = 1.32 [0.74–2.35] | OR = 1.32 [0.65–2.68] | ||
Loss ≥ 10 ETDRS letters | 4 studies (n = 1611)*** | RR = 0.31 [0.09–1.04] | RR = 0.31 [0.09–1.09] |
OR = 0.28 [0.08–0.99] | OR = 0.27 [0.08–0.94] | ||
Gain ≥ 15 ETDRS letters | 4 studies (n = 1611)*** | RR = 1.49 [0.78–2.85] | RR = 1.49 [0.78–2.85] |
OR = 1.74 [0.83–3.65] | OR = 1.74 [0.83–3.65] | ||
Loss ≥ 15 ETDRS letters | 4 studies (n = 1611)*** | RR = 0.24 [0.03–1.90] | RR = 0.26 [0.03–2.11] |
OR = 0.23 [0.03–1.86] | OR = 0.23 [0.03–1.86] |